NCT04885543

Brief Summary

This study was conducted in three African countries on four COVID-19 care centers (CCCs). The CCCs were set up in collaboration with a medical NGO with long experience in recording and monitoring data for cohorts and clinical trials in emergency contexts. The data were recorded using the WHO COVID-19 rapid core case report form.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,495

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 6, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 13, 2021

Completed
Last Updated

May 13, 2021

Status Verified

May 1, 2021

Enrollment Period

1 year

First QC Date

May 6, 2021

Last Update Submit

May 11, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mortality

    In hospital mortality

    During hospitalization, with an average of 11 days

Secondary Outcomes (1)

  • Clinical worsening

    Hospitalization, with an average of 11 days

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People hospitalized with symptomatic of COVID-19 and a positive RT-PCR SARS-CoV-2 test

You may qualify if:

  • SARS-CoV-2 positive at RT-PCR

You may not qualify if:

  • Asymptomatic patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Chu Tengandogo

Ouagadougou, BP104, Burkina Faso

Location

Clinique Princesse Sarah

Ouagadougou, BP51145, Burkina Faso

Location

Chu Donka

Conakry, BP834, Guinea

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Denis Malvy, Pr

    CHU Bordeaux, INSERM 1219

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2021

First Posted

May 13, 2021

Study Start

March 1, 2020

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

May 13, 2021

Record last verified: 2021-05

Locations